EVs that are isolated from the plasma of NSCLC patients can also contain the mRNA of PD-L1, and the number of copies of the vesicular PD-L1 mRNA per ml of blood associates with a response to the anti-PD-1 antibodies nivolumab and pembrolizumab [73]. This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.